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Abstract
Clinical data from electronic medical records, registries
or trials provide a large source of information to apply
machine learning methods in order to foster precision
medicine, e.g. by finding new disease phenotypes or
performing individual disease prediction. However, to
take full advantage of deep learning methods on clini-
cal data, architectures are necessary that 1) are robust
with respect to missing and wrong values, and 2) can
deal with highly variable-sized lists and long-term de-
pendencies of individual diagnosis, procedures, mea-
surements and medication prescriptions. In this work,
we elaborate limitations of fully-connected neural net-
works and classical machine learning methods in this
context and propose AdaptiveNet, a novel recurrent
neural network architecture, which can deal with multi-
ple lists of different events, alleviating the aforemen-
tioned limitations. We employ the architecture to the
problem of disease progression prediction in rheuma-
toid arthritis using the Swiss Clinical Quality Manage-
ment registry, which contains over 10.000 patients and
more than 65.000 patient visits. Our proposed approach
leads to more compact representations and outperforms
the classical baselines.
Introduction
Driven by increased computational power and larger
datasets, deep learning (DL) techniques have success-
fully been applied to process and understand complex
data (LeCun, Bengio, and Hinton 2015). In recent years,
the adoption of electronic medical records (EMRs),
registries and trial datasets has heavily increased the
amount of captured patient data from thousands up
to millions of individuals patients. Those datasets can
be used to predict individual disease progression and
outcomes in medicine to assist patients and doctors.
Especially deep learning methods are more and more
applied to process clinical data (Miotto et al. 2016;
Shickel et al. 2017; Rajkomar et al. 2018;
Hoang and Ho 2019) and learn from former experi-
ences on a large scale as a potential tool to guide treatment
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Figure 1: Scheme of AdaptiveNet, which projects visits and
medication adjustments to the same latent space using en-
coder networks φvisit and φmed, where the output vectors
φ(·)(·) have the same length. The sorted list of encoded
events are pooled by an LSTM to compute a fixed-length
encoded patient history. The final output yˆ is computed by
the network module ρ.
and surveillance (Komorowski et al. 2018).
To establish high-quality decision making systems for
clinical datasets, machine learning (ML) methods have to be
able to deal with the varying structure of the data, containing
variable-sized lists of diagnosis, procedures, measurements
and medication prescriptions. Capturing long-term de-
pendencies and handling irregular event sequences with
variable time spans in between is crucial to model complex
disease progressions of patients in personalized medicine.
Classical ML models, such as Random Forests (RFs)
(Breiman 2001), and fully-connected networks (FCNs) or
recurrent neural networks (RNNs) were applied success-
fully to predict disease progression (Vodencarevic et al.
2018) and disease outcomes (Kourou et al. 2015). However,
classical FCN architectures1 are limited to a fixed number of
1As architecture we understand the full specification of inter-
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input features. As consequence, these models can only con-
sider a fixed number of events, such as visits or medication
prescriptions and adjustments. As a simple workaround,
only the last N visits and M medication prescriptions can
be considered and older entries ignored. In case patients
have less than N entries for visits or M medication ad-
justments, dummy values have to be used to guarantee a
fixed number of input features. However, depending on the
choice ofN andM , the full patient history is not considered.
Classical recurrent neural networks, such as long short-
term memories (LSTMs) (Hochreiter and Schmidhuber
1997) can deal with variable-sized inputs and can handle
irregularly timed events. In previous work, LSTMs were
used for outcome prediction in intensive care units (Lipton
et al. 2015), heart failure prediction (Maragatham and Devi
2019), Alzheimer’s disease progression prediction (Lee
et al. 2019) and other applications (Baytas et al. 2017;
Pham et al. 2017). However, the proposed architectures can
only deal with one variable-sized list of one feature repre-
sentation, which is limiting when working with clinical data.
In this work, we aim at exploiting and unifying all available
patient data. The resulting neural network architecture has to
be able to deal with multiple variable-sized lists of different
events like visits, medication adjustments or imaging, which
all have different feature representations. In (Liu et al. 2018;
Liu et al. 2019), this problem was approached by using large
one-hot encodings, which contain features for all different
event types. However, this approach leads to a high amount
of dummy values and has limited flexibility.
We propose AdaptiveNet, a recurrent neural network ar-
chitecture that can be trained in an end-to-end fashion. The
scheme of the architecture is shown in Figure 1. Adap-
tiveNet can deal with multiple variable-sized lists of differ-
ent event types by using multiple fully-connected encoding
network modules to project all event types to the same latent
space. Then, the sorted list of latent event representations is
fed to a recurrent unit in order to compute a latent represen-
tation describing the full patients history. We employ Adap-
tiveNet for the problem of disease progression prediction in
rheumatoid arthritis (RA) and evaluate the performance on
the Swiss Clinical Quality Management (SCQM) dataset.
Related Work
Data in health care and biology often contains a variety of
missing and wrong values. Previous work already addressed
missing values in time series (Schafer and Graham 2002),
but did not provide good performance when the missing
rate was too high and inadequate samples were kept. While
classical methods can omit missing data by performing
analysis only on the observed data, for deep neural network
architectures this is not straightforward. A possible solution
is to fill in the missing values with substituted values,
e.g. by smoothing or interpolation (Nancy, Khanna, and
actions between different network modules, in- and outputs. In
the following, we denote classical fully-connected neural networks
without any extensions as FCN.
Arputharaj 2017). In (Rubin 1976), it was shown that
missing values can provide useful information about target
labels in supervised learning tasks. In (Che et al. 2016) this
fact was exploited by using recurrent neural networks that
are aware of missing values.
Other network architectures, such as convolutional
neural networks (CNNs) (Nguyen et al. 2016), Transformer
architectures (Li et al. 2019) or graph neural networks
(GNNs) (Zhou et al. 2018) were also used to process
clinical data (Choi et al. 2019). In contrast to CNNs, which
are limited to their initial grid size, Transformers and GNNs
are able to deal with variable-sized input lists. In general,
these architectures could be extended to deal with multiple
variable-sized lists in the same manner as described in this
work for RNNs. However, since we want to cover temporal
long-term dependencies in timeseries, we focus on RNNs.
Projecting objects to a latent space and pooling the
latent vectors was already proposed in the Deep Set archi-
tecture (Zaheer et al. 2017). As pooling component, any
permutation-invariant operator can be used, such as the
sum. This approach was extended in (Huegle et al. 2019)
by projecting different object types to the same latent space
using multiple encoders and pooling the objects by the sum
in the context of off-policy reinforcement learning. In this
work, we use a recurrent unit as pooling function to cover
temporal dependencies.
In the application of RA, there is only few prior work
on disease progression prediction. In (Vodencarevic et al.
2018), rheumatic flares were predicted using Logistic Re-
gression and Random Forests. Defining flares by DAS28-
EST ≥ 3.2 and Swollen Joint Count 28 ≥ 2, they achieved
an AUC of about 80% in a small study with a group of
314 carefully selected patients from the Utrecht Patient Ori-
ented Database. Disease detection, which is less sophisti-
cated than disease progression prediction, was performed
in (Shiezadeh, Sajedi, and Aflakie 2015). Using an ensem-
ble of decision trees, they achieved an accuracy of 85% and
a sensitivity and specificity of 44% and 74% on a dataset
of around 2500 patients referred to a rheumatology clinic
in Iran. (Lin et al. 2013) performed disease detection based
on classical ML methods trained on > 2500 clinical notes
and lab values. With an SVM, they achieved the best perfor-
mance with an AUC score of 0.831.
Methods
In this section, we describe the disease progression predic-
tion problem and how input samples can be generated from
clinical datasets. Finally, the architecture of AdaptiveNet is
explained in detail.
Disease Progression Prediction
Disease progression prediction based on a clinical dataset
can be modeled as time-series prediction, where for a patient
at time point t the future disease activity at time point t +
∆t is predicted. The dataset consists of records for a set of
Algorithm 1: Sample Generation from RecordsR
1 Initialize feature array X and labels y.
2 for patient recordRj ∈ R do
3 for visit time point t ∈ T visitj do
4 // For all follow up visits before the next
medication adjustment:
5 T follow-upj ← {t′ ∈ T visitj | t′ > t and
6 6 ∃tm ∈ T medj s.t. t ≤ tm ≤ t′}
7 for follow up t′ ∈ T follow-upj do
8 ∆t← t′ − t
9 add Rj(t,∆t) to X
10 add scorej(t+ ∆t)− scorej(t) to y
patients R = ⋃j Rj . Records can contain general patient
information (e.g. age, gender, antibody-status) and multiple
list of events. The subset Rj(t) ⊆ Rj , denotes all records of
a patient j collected until time point t with
Rj(t) = {epatient(t)} ∪ Evisit(t) ∪ Emed(t),
where epatient(t) contains general patient information col-
lected until time point t. Ek(t) is a list of events collected
until time point t, where
Ek(t) = {ek(te) | ek(te) ∈ Rj and te ≤ t},
for all event types k ∈ {visit,med}. Visit events contain in-
formation like joint swelling or patient reported outcomes
(e.g. joint pain, morning stiffness and HAQ) and lab val-
ues (e.g. CRP, BSR). Medication events contain adjustment
information, such as drug type and dose. In the same man-
ner, further lists of other event types could be added, such
as imaging data (e.g. MRI, radiograph). Considering records
Rj(t) as input, we aim to learn a function f : (Rj(t),∆t)→
R that maps the records at time point t to the expected
change of the disease level scorej until time t+ ∆t with
f(Rj(t),∆t) = scorej(t+ ∆t)− scorej(t).
To account for variable time spans, for all events, the time
distance ∆t to the prediction time point is added as addi-
tional input feature. Records with included time feature are
denoted as Rj(t,∆t) and event lists with E(·)(t,∆t). If not
denoted explicitly in the following, we assume that ∆t is
included in all records and lists.
Sample Generation from Clinical Data
To train ML models on a clinical dataset in a supervised
fashion, input samples and the corresponding labels are con-
structed over all patient records Rj by iterating over the list
of visit time points T visitj and over all follow-up visits until
the next medication adjustment. The list of time points for
medication treatments is denoted as T medj . The sample gen-
eration procedure is shown in Algorithm 1.
AdaptiveNet
In order to deal with the above defined patient records Rj(t)
and the corresponding variable-sized event lists E(·)(t) for
a time point t, we propose the neural network architec-
ture AdaptiveNet, which is able to deal with K input sets
E1, ..., EK , where every set can have variable length and
different feature representations. With neural network mod-
ules φ1, ..., φK , every element of theK lists can be projected
to a latent space and a sorted list of latent events can be com-
puted as
Ψ(Rj(t)) = Ψ(E
1, ..., EK) = sort
⋃
k
⋃
e∈Ek(t)
φk(e)
 ,
with 1 ≤ k ≤ K, sorted according to the time points of
the events. The output vectors φk(·) ∈ RF of the encoder
networks φk have the same length F . These network mod-
ules can have an arbitrary architecture. In this work, we use
fully-connected network modules to deal with numerical and
categorical input features. We additionally propose to share
the parameters of the last layer over all encoder networks.
Then, φk(·) can be seen as a projection of all input objects
to the same encoded event space (effects of which we inves-
tigate further in the results). The prediction yˆ of the network
is then computed as
yˆ(Rj(t)) = ρ
(
LSTM
[
Ψ(Rj(t))
]
|| epatient
)
,
where || denotes concatenation of the vectors and ρ is a fully-
connected network module. In this work, we use an LSTM
(Hochreiter and Schmidhuber 1997) to pool the events by a
recurrent unit. The scheme of the architecture is shown in
Figure 1. To tackle the disease progression prediction prob-
lem, in this work, we use two encoder modules φ1, φ2 for
the set of event types {visit,med}. It is straightforward to
add other event types, for example imaging data. In this case,
the encoder module could consist of a convolutional neural
network, which can optionally be pre-trained and have fixed
weights.
Experimental Setup
In this section, we first explain the dataset and describe how
to perform disease progression prediction in RA. After that,
we explain baselines and training details, such as hyperpa-
rameter optimization and architectural choices.
Data Set
In this work, we use the Swiss Clinical Quality Manage-
ment (SCQM) database (Uitz et al. 2000) for rheumatic dis-
eases, which includes data of over 10.000 patients with RA,
assessed during consultations and via the mySCQM online
application. The database consists of general patient infor-
mation, clinical data, disease characteristics, ultrasound, ra-
diographs, lab values, medication treatments and patient re-
ported outcome (HAQ, RADAI-5, SF12, EuroQol). Patients
were followed-up with one to four visits yearly and clinical
information was updated every time. The data collection was
approved by a national review board and all individuals will-
ing to participate, signing an informed consent form before
enrolment in accordance with the Declaration of Helsinki.
Numerical Missing [%] Mean (± Std.)
minimal disease activity 1.6 1.3 (±1.1)
number swollen joints 6.6 3.3 (±4.6)
number painful joints 6.9 3.5 (±5.3)
bsr 14.6 18.5 (±17.1)
das28bsr score 16.4 3.2 (±1.4)
pain level∗ 22.4 3.3 (±2.7)
disease activity 22.7 3.4 (±2.7)
index∗
haq score 27.8 0.8 (±0.7)
weight [kg] 36.5 70.7 (±15.6)
height [cm] 40.8 165.3 (±12.2)
crp 45.4 7.32 (±12.7)
∆t (5y history) 0.0 2.2 (±1.4)
Categorical Values [%]
morning stiffness∗ 22.7 all day (1.9%)
< 0.5h (15.4%)
0.5-1h (12.0%)
> 4h (1.6%)
12h (6.1%)
24h (3.5%)
no (36.8%)
smoker 60.2 current (9.3%)
former (12.3%)
never (18.2%)
Table 1: Visit features. The values for ∆t are shown for a
prediction horizon of 1 year and a maximum history length
of 5 years. (∗) This score is a rheumatoid arthritis disease
activity index (RADAI).
Disease Progression Prediction in RA
To represent the disease level, we use the hybrid score
DAS28-BSR as prediction target, which contains DAS28
(Disease Activity Score 28) and the inflammation blood-
marker BSR (blood sedimentation rate). DAS28 defines the
disease activity based on 28 joints (number of swollen joints,
number of painful joints and questionnaires). For train-
ing and evaluation, we consider only visits with available
DAS28-BSR score. We focus on 13 visit features, selected
by a medical expert. All visit features are shown in Ta-
ble 1. Additionally, we consider eight medications. The cor-
responding features are listed in Table 2 and general patient
features in Table 3.
Baselines
As baselines, we consider a Naive Baseline where we set
f(Rj(t),∆t) ≈ 0, which means no change in the dis-
ease level. Further, we compare to a Random Forest (en-
semble of decision trees) and a classical Fully-Connected
Network. In order to deal with the variable patient history
lengths of the clinical dataset, for both RF and the FCN ar-
chitecture the inputs have to be padded with dummy values
(e.g. −1). Since we want to consider the full patient his-
tory without any loss of information, we pad the input un-
til the maximum number of visit features is reached for the
patient with the longest history, and analogously for medi-
cation features. Considering a maximum history length over
Categorical Value Pct. [%]
drug dmard mtx 24.1
prednison 16.8
adalimumab 7.9
etanercept 7.3
tocilizumab 4.0
abatacept 4.0
rituximab 3.5
golimumab 2.4
other 30.1
type prednison 16.8
dmard 24.1
biologic 29.0
other 30.1
dose no 41.3
< 10 [mg] 9.6
10 - 15 [mg] 12.6
> 15 [mg] 36.5
Numerical Missing [%] Mean (± Std.)
∆t (5y history) 0.0 2.2 (±1.3)
Table 2: Medication features.
Numerical Missing [%] Mean (± Std.)
age 0.0 58.8 (±13.0)
disease duration 2.7 12.2 (±9.5)
Categorical Values [%]
gender 0.0 male (26.0%)
female (74.0%)
r-factor 9.1 yes (62.9%)
no (28.0%)
anti-ccp 31.6 yes (42.4%)
no (26.0%)
Table 3: General patient features.
many years can lead to a huge input size and large amount of
dummy values, complicating reliable estimation of relevant
correlations considerably. For a history length of 5 years, the
input sizes of the RF and FCN are 1178, due to a maximum
of 35 visits for one patient. In contrast, AdaptiveNet has 8
input features for general patient information, 21 input fea-
tures for visits and 18 features for medications. For a history
length of 5 years, patients have in mean 6.3 (±5.3) visits
and 2.5 (±2.7) medication adjustments.
Training
To train our models, we considered only patients with more
than two visits and a minimum prediction horizon of 3
months up to a maximum of one year. In total, we trained
on 28601 samples. For preprocessing, we scaled all features
in the range (0, 1). The final architecture of AdaptiveNet
is shown in Table 4. As activation function, rectified linear
units (ReLU) were used for all hidden layers. Additionally,
we used l1-regularization for the weights of the network. For
the FCN, we used dropout of 0.1, l1-regularization and three
hidden layers of hidden dimension 32. For the RF, 100 tree
AdaptiveNet
Input(B × seqvisit × 21) and Input(B × seqmed × 18)
φvisit: FC(100)∗, φmed: FC(100)∗
LSTM(·)
concat(·, Input(B × 8))
FC(100), FC(100)
Linear(1)
Table 4: Architecture of AdaptiveNet, where FC denotes
fully-connected layers, seq(·) variable-sized lists of events
and B the batch size. (∗) A second FC(100) layer is used in
experiments with parameter-sharing for the encoders.
Model Parameter Config. Space
RF max depth [8, 10, 12, 15]
FCN num hidden layers [2, 3, 4]
hidden dim [32, 64, 100]
dropout rate [0.0, 0.1, 0.25]
AdaptiveNet φ(·): hidden dim [32, 64, 100]
φ(·): num hidden layers [1,2]∗
ρ: hidden dim [64, 100, 200]
ρ: num hidden layers [1,2, 3]
dropout rate [0.0, 0.1, 0.25]
Table 5: Configuration spaces of the different approaches.
The best performing architectural choices are shown in bold.
(∗) For experiments with parameter-sharing in the last layer,
one additional layer of the same hidden dimension is added.
estimators were used with a maximum depth of 12. To train
the neural networks, weights w are updated in supervised
fashion via gradient descent on a minibatch of samples X
and labels y of size B using the update rule:
w ← w − α∇wL(w),
with learning rate α and loss L. The loss is computed as:
L(w) =
1
B
B∑
i=1
(yi − yˆ(Xi))2.
All architectures were trained with a batch size of B =
256 for 7000 steps (batches of samples). For optimization,
we used the Adam optimizer (Kingma and Ba 2014) with a
learning rate of 1e−4. To evaluate fairly, all models were op-
timized using grid search, including the baselines. The con-
figuration spaces for all methods can be found in Table 5.
Results
To evaluate the performance of all models, we use 5-fold
cross validation, where samples and corresponding labels
were generated as shown in Algorithm 1. The results are
shown in Figure 2 for a prediction horizon of one year for
all methods and different maximum history lengths of 6
5 year
 history
1 year
 history
6 months
 history
0.9
1.0
1.1
1.2
1.3
1.4
Naive Baseline
Random Forest
FCN
AdaptiveNet
Figure 2: Mean squared error of the disease progression pre-
diction for different maximum history lengths in a range
from 5 years to 6 months. The prediction horizon is 1 year.
months to 5 years.
All ML methods outperform the Naive Baseline sig-
nificantly, which has a MSE of 1.369. The performance
of the RF decreases with increasing history size from a
MSE 0.983 for 6 months to a MSE of 1.058, probably
due to the huge amount of input features. In contrast, both
neural network architectures are able to profit from longer
histories. With a MSE of 0.988 for history of 6 months,
the FCN shows slightly worse performance than the RF.
However, for longer histories, the FCN outperforms the RF,
showing MSEs of 0.953 for 1 year and 1.058 for 5 years.
The best performance over all history lengths is achieved
by AdaptiveNet with a MSE of 0.957 for 6 months up to
0.907 for a history length of 5 years, which corresponds to
an error of 7.94% in the range of the target value (change of
DAS28-BSR).
For further evaluation, we use the trained regression
model to perform classification. Defining two classes
as active disease (DAS28-BSR ≤ 2.6) and in remission
(DAS28-BSR < 2.6), we can classify between future
disease levels by estimating the absolute disease level with
f abs(Rj(t),∆t) = scorej(t) + f(Rj(t),∆t). AdaptiveNet
achieves an accuracy of 76% and an Area Under the Curve
(AUC) score of 0.735. Please note that these results can
not directly be compared to the performance of the flare
prediction approach shown in (Vodencarevic et al. 2018)
due to different definitions of active disease levels and
different datasets (10.000 patients in this study vs. 314
patients).
Using parameter sharing in the last layer in the φ(·) mod-
ules, the network performs slightly better for long histories.
With parameter sharing, the MSE of the disease progression
prediction for AdaptiveNet for a considered maximum his-
100 50 0 50 100
100
50
0
50
100
Visits
Medications
Figure 3: t-SNE visualization of the latent representations
φvisit(·) and φmed(·) with shared parameters in the last layer.
tory of 5 years decreases from 0.923 to 0.899. The fact, that
the individual latent representations for the different events
are separated in our architecture makes it possible to charac-
terize the structure of the encoded event space, which would
not be possible for the other methods. We visualize the la-
tent vectors φk(·) using the t-distributed Stochastic Neigh-
bor Embedding (t-SNE) (van der Maaten and Hinton 2008)
algorithm, which is a nonlinear dimensionality reduction
method to reduce high-dimensional data to lower dimen-
sions for visualization. Figure 3 shows the t-SNE plot for
6000 latent representations. As can be seen in the plot, the
learned representations for visits and medications are nicely
clustered and well separated, which partly explains the good
performance of this architecture.
Conclusion
AdaptiveNet provides a flexible architecture to deal with
multiple variable-sized lists of clinical events of different
types, such as clinical visits or medication adjustments. The
flexibility of the architecture allows to exploit and integrate
all available data into the decision making process in a uni-
fied and compact manner. Compared to classical approaches,
AdaptiveNet is more robust in disease prediction, avoid-
ing missing values and handling irregular visits by a recur-
rent unit. AdaptiveNet can be applied for various ML appli-
cations based on clinical datasets like EMRs, registries or
trials. We are convinced that flexible and integrative deep
learning systems such as AdaptiveNet can boost personal-
ized medicine by considering as much data as possible to
create high-quality machine-learned evidence.
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